|
1
|
Gao Q, Shen W, Qin W, Zheng C, Zhang M,
Zeng C, Wang S, Wang J, Zhu X and Liu Z: Treatment of db/db
diabetic mice with triptolide: A novel therapy for diabetic
nephropathy. Nephrol Dial Transplant. 25:3539–3547. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Forbes JM, Coughlan MT and Cooper ME:
Oxidative stress as a major culprit in kidney disease in diabetes.
Diabetes. 57:1446–1454. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rossing P, Hougaard P and Parving HH: Risk
factors for development of incipient and overt diabetic nephropathy
in type 1 diabetic patients: A 10-year prospective observational
study. Diabetes Care. 25:859–864. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sawicki PT, Didjurgeit U, Mühlhauser I,
Bender R, Heinemann L and Berger M: Smoking is associated with
progression of diabetic nephropathy. Diabetes Care. 17:126–131.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mühlhauser I, Bender R, Bott U, Jörgens V,
Grüsser M, Wagener W, Overmann H and Berger M: Cigarette smoking
and progression of retinopathy and nephropathy in type 1 diabetes.
Diabet Med. 13:536–543. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
De Cosmo S, Lamacchia O, Rauseo A, Viti R,
Gesualdo L, Pilotti A, Trischitta V and Cignarelli M: Cigarette
smoking is associated with low glomerular filtration rate in male
patients with type 2 diabetes. Diabetes Care. 11:2467–2470. 2006.
View Article : Google Scholar
|
|
7
|
Hallan SI and Orth SR: Smoking is a risk
factor in the progression to kidney failure. Kidney Int.
80:516–523. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Winer S, Chan Y, Paltser G, Truong D, Tsui
H, Bahrami J, Dorfman R, Wang Y, Zielenski J, Mastronardi F, et al:
Normalization of obesity-associated insulin resistance through
immunotherapy. Nat Med. 15:921–929. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Aggarwal BB, Sundaram C, Malani N and
Ichikawa H: Curcumin: The Indian solid gold. Adv Exp Med Biol.
595:1–75. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sharma S, Kulkarni SK and Chopra K:
Curcumin, the active principle of turmeric (Curcuma longa),
ameliorates diabetic nephropathy in rats. Clin Exp Pharmacol
Physiol. 33:940–945. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Meghana K, Sanjeev G and Ramesh B:
Curcumin prevents streptozotocin-induced islet damage by scavenging
free radicals: A prophylactic and protective role. Eur J Pharmacol.
577:183–191. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chiu J, Khan ZA, Farhangkhoee H and
Chakrabarti S: Curcumin prevents diabetes-associated abnormalities
in the kidneys by inhibiting p300 and nuclear factor-kappaB.
Nutrition. 25:964–972. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Suvarna SK, Layton C and Bancroft JD: The
hematoxylins and eosin. Bancroft's Theory and Practice of
Histological Techniques. 7th edition. Churchill Livingstone;
London: pp. 172–186. 2013
|
|
14
|
Liu DG and Wang TM: Role of connective
tissue growth factor in experimental radiation nephropathy in rats.
Chin Med J (Engl). 121:1925–1931. 2008.
|
|
15
|
Zheng CX, Chen ZH, Zeng CH, Qin WS, Li LS
and Liu ZH: Triptolide protects podocytes from puromycin
aminonucleoside induced injury in vivo and in vitro. Kidney Int.
74:596–612. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gu L, Gao Q, Ni L, Wang M and Shen F:
Fasudil inhibits epithelial-myofibroblast transdifferentiation of
human renal tubular epithelial HK-2 cells induced by high glucose.
Chem Pharm Bull (Tokyo). 61:688–694. 2013. View Article : Google Scholar
|
|
17
|
Lan X, Rai P, Chandel N, Cheng K, Lederman
R, Saleem MA, Mathieson PW, Husain M, Crosson JT, Gupta K, et al:
Morphine induces albuminuria by compromising podocyte integrity.
PLoS One. 8:e557482013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Benzing T: Signaling at the slit
diaphragm. J Am Soc Nephrol. 15:1382–1391. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Satriano J, Mansoury H, Deng A, Sharma K,
Vallon V, Blantz RC and Thomson SC: Transition of kidney tubule
cells to a senescent phenotype in early experimental diabetes. Am J
Physiol Cell Physiol. 299:C374–C380. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Miyauchi M, Toyoda M, Kobayashi K, Abe M,
Kobayashi T, Kato M, Yamamoto N, Kimura M, Umezono T and Suzuki D:
Hypertrophy and loss of podocytes in diabetic nephropathy. Intern
Med. 48:1615–1620. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zheng M1, Lv LL, Ni J, Ni HF, Li Q, Ma KL
and Liu BC: Urinary podocyte-associated mRNA profile in various
stages of diabetic nephropathy. PLoS One. 6:e204312011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dousdampanis P, Trigka K and Fourtounas C:
Prevalence of anemia in patients with type II diabetes and mild to
moderate chronic kidney disease and the impact of anti-RAS
medications. Saudi J Kidney Dis Transpl. 25:552–557. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Singh DK, Winocour P and Farrington K:
Erythropoietic stress and anemia in diabetes mellitus. Nat Rev
Endocrinol. 5:204–210. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Habek D, Habek JC, Ivanisević M and
Djelmis J: Fetal tobacco syndrome and perinatal outcome. Fetal
Diagn Ther. 6:367–371. 2002. View Article : Google Scholar
|
|
25
|
Gouva C, Nikolopoulos P, Ioannidis JP and
Siamopoulos KC: Treating anemia early in renal failure patients
slows the decline of renal function: A randomized controlled trial.
Kidney Int. 66:753–760. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Martínez-Morúa A, Soto-Urquieta MG,
Franco-Robles E, Zúñiga-Trujillo I, Campos-Cervantes A,
Pérez-Vázquez V and Ramírez-Emiliano J: Curcumin decreases
oxidative stress in mitochondria isolated from liver and kidneys of
high-fat diet-induced obese mice. J Asian Nat Prod Res. 15:905–915.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ishigaki N, Yamamoto T, Shimizu Y,
Kobayashi K, Yatoh S, Sone H, Takahashi A, Suzuki H, Yamagata K,
Yamada N and Shimano H: Involvement of glomerular SREBP-1c in
diabetic nephropathy. Biochem Biophys Res Commun. 364:502–508.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Uttarwar L, Gao B, Ingram AJ and Krepinsky
JC: SREBP-1 activation by glucose mediates TGF-β upregulation in
mesangial cells. Am J Physiol Renal Physiol. 302:F329–F341. 2012.
View Article : Google Scholar
|
|
29
|
Jun H, Song Z, Chen W, Zanhua R, Yonghong
S, Shuxia L and Huijun D: In vivo and in vitro effects of SREBP-1
on diabetic renal tubular lipid accumulation and RNAi-mediated gene
silencing study. Histochem Cell Biol. 3:327–345. 2009. View Article : Google Scholar
|
|
30
|
Basile DP: Transforming growth factor-beta
as a target for treatment in diabetic nephropathy. Am J Kidney Dis.
38:887–892. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lv S, Liu G, Sun AG, Wang J, Cheng J, Wang
W, Liu X, Nie H and Guan G: Mesenchymal stem cells ameliorate
diabetic glomerular fibrosis in vivo and in vitro by inhibiting
TGF-β signalling via secretion of bone morphogenetic protein 7.
Diab Vasc Dis Res. 11:251–261. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Seoane-Collazo P, Martínez de Morentin PB,
Fernø J, Diéguez C, Nogueiras R and López M: Nicotine improves
obesity and hepatic steatosis and ER stress in diet-induced obese
male rats. Endocrinology. 155:1679–1689. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wen X, Zeng Y, Liu L, Zhang H, Xu W, Li N
and Jia X: Zhenqing recipe alleviates diabetic nephropathy in
experimental type 2 diabetic rats through suppression of SREBP-1c.
J Ethnopharmacol. 142:144–150. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Luan J, Li W, Han J, Zhang W, Gong H and
Ma R: Renal protection of in vivo administration of tempol in
streptozotocin-induced diabetic rats. J Pharmacol Sci. 119:167–176.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Simsek N, Kaya M, Kara A, Can I, Karadeniz
A and Kalkan Y: Effects of melatonin on islet neogenesis and beta
cell apoptosis in streptozotocin-induced diabetic rats: An
immunohistochemical study. Domest Anim Endocrinol. 43:47–57. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Akinola OB, Caxton Martins EA and Dini L:
Chronic treatment with ethanolic extract of the leaves of
Azadirachta indica ameliorates lesions of pancreatic islets in
streptozotocin diabetes. Int J Morphol. 28:291–302. 2010.
|
|
37
|
Bruin JE, Kellenberger LD, Gerstein HC,
Morrison KM and Holloway AC: Fetal and neonatal nicotine exposure
and postnatal glucose homeostasis: Identifying critical windows of
exposure. Journal of Endocrinology. 194:171–178. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bruin JE, Petre MA, Lehman MA, Raha S,
Gerstein HC, Morrison KM and Holloway AC: Maternal nicotine
exposure increases oxidative stress in the offspring. Free Radic
Biol Med. 44:1919–1925. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Abdul-Hamid M and Moustafa N: Protective
effect of curcumin on histopathology and ultrastructure of pancreas
in the alloxan treated rats for induction of diabetes. J Appl Zool.
66:169–179. 2013. View Article : Google Scholar
|
|
40
|
Ong AC, Jowett TP, Firth JD, Burton S,
Kitamura M and Fine LG: Human tubular-derived endothelin in the
paracrine regulation of renal interstitial fibroblast function. Exp
Nephrol. 2:1341994.PubMed/NCBI
|
|
41
|
Soetikno V, Suzuki K, Veeraveedu PT,
Arumugam S, Lakshmanan AP, Sone H and Watanabe K: Molecular
understanding of curcumin in diabetic nephropathy. Drug Discov
Today. 18:756–63. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sassy-Prigent C, Heudes D, Mandet C,
Bélair MF, Michel O, Perdereau B, Bariéty J and Bruneval P: Early
glomerular macrophage recruitment in streptozotocin-induced
diabetic rats. Diabetes. 49:466–475. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Soetikno V, Sari FR, Veeraveedu PT,
Thandavarayan RA, Harima M, Sukumaran V, Lakshmanan AP, Suzuki K,
Kawachi H and Watanabe K: Curcumin ameliorates macrophage
infiltration by inhibiting NF-κB activation and proinflammatory
cytokines in streptozotocin induced-diabetic nephropathy. Nutr
Metab (Lond). 8:352001. View Article : Google Scholar
|
|
44
|
Asaba K, Tojo A, Onozato ML, Goto A, Quinn
MT, Fujita T and Wilcox CS: Effects of NADPH oxidase inhibitor in
diabetic nephropathy. Kidney Int. 67:1890–1898. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Goel A, Kunnumakkara AB and Aggarwal BB:
Curcumin as 'Curecumin': From kitchen to clinic. Biochem Pharmacol.
75:787–809. 2008. View Article : Google Scholar
|
